| Date | Time | Source | Announcement |
|---|---|---|---|
| 30 Jun 2021 | 12:50 PM | Result of AGM | |
| 22 Jun 2021 | 07:00 AM | Application filed for protected linearised synt... | |
| 18 Jun 2021 | 07:00 AM | Annual General Meeting 2021 | |
| 04 Jun 2021 | 07:00 AM | Notice of AGM and Posting of Accounts | |
| 03 Jun 2021 | 07:00 AM | Final Results | |
| 27 Apr 2021 | 07:00 AM | Evaluation licence for muscular dystrophy vector | |
| 26 Feb 2021 | 07:00 AM | Director/PDMR Shareholding | |
| 25 Feb 2021 | 09:05 AM | Second Price Monitoring Extn | |
| 25 Feb 2021 | 09:00 AM | Price Monitoring Extension | |
| 22 Feb 2021 | 11:00 AM | Price Monitoring Extension | |
| 22 Feb 2021 | 09:31 AM | Holding(s) in Company | |
| 19 Feb 2021 | 05:35 PM | Holding(s) in Company | |
| 19 Feb 2021 | 04:41 PM | Second Price Monitoring Extn | |
| 19 Feb 2021 | 04:36 PM | Price Monitoring Extension | |
| 17 Feb 2021 | 07:00 AM | Admission to Trading on AIM and First Day of De... |
4basebio is a life sciences company focused on DNA manufacturing and delivery for gene therapies and gene-based vaccines.
4basebio share price launched at 450p in 2021.